Dr. Amany Keruakous sat down for an interview with CURE, in which she discussed how bispecific antibodies for multiple ...

The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies are immune proteins that our bodies produce to help fight off infection. Where they recognize and bind a pathogen — and how — can give important clues to the microbe’s vulnerabilities. Fred ...

When the body encounters an infectious agent like SARS-CoV-2, it produces antibodies that detect and neutralize it. The antibodies bind to distinct proteins on the virus’s surface called antigens. As ...

Researchers at Texas Biologics at The University of Texas at Austin, working with scientists internationally, have made an ...

For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...

Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...

One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Bispecific antibodies offer a “targeted and effective alternative” for the ...